Prescription drug prices in the United States have been a hot-button issue for decades. Nearly 25% of patients report struggling to afford the medications they need, making this issue critical. Yet the connection between drug prices and patient affordability is complex and often poorly understood. Groundbreaking ZS research offers a clear view of what’s truly happening with patient affordability—and what both policymakers and the pharmaceutical industry often overlook when addressing this urgent challenge.
During this webinar, we share insights from our research on the following topics:
- Identify the consequences of patient affordability and access issues
- Share ZS’s findings on the sources of patient affordability and how they differ from public perception
- Explore ways policymakers and pharmaceutical companies could have a more productive dialogue on patient affordability
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
